Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
5 tulemused
Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a national stage filing under section 371 of International Application No. PCT/EP2016/053172, filed on Feb. 15, 2016, and published on Aug. 25, 2016 as WO 2016/131776, which claims priority to Great Britain Application No. 1502567.9, filed
N-substituted tetrahydroisoquinoline benzamides/benzene sulfonamides as anti-cancer agents
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present disclosure is generally related to N-substituted tetrahydroisoquinoline benzamide and benzene sulfonamide compounds and their use in modulating the proliferation of transformed (cancer) cells.
BACKGROUND
Cancer is a disease in which cells in the body grow out of control.
Benzimidazolylidene propane-1,3 dione derivative or salt thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present invention relates to a novel propane-1,3-dione derivative useful as a medicament, particularly a therapeutic agent for sex hormone dependent diseases.
BACKGROUND OF THE INVENTION
It is known that a hypothalamic hormone or a pituitary hormone is concerned in the secretion
Benzimidazolylidene propane-1,3-dione derivative or salt thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present invention relates to a novel propane-1,3-dione derivative useful as a medicament, particularly a therapeutic agent for sex hormone dependent diseases.
BACKGROUND OF THE INVENTION
It is known that a hypothalamic hormone or a pituitary hormone is concerned in the secretion
Process for producing optically active naphthalene derivative and optical resolver therefor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present invention relates to a production method of an optically active naphthalene derivative having a pharmacological action, particularly a steroid C.sub.17,20 -lyase inhibitory activity, a reagent for optical resolution thereof and a production method of the reagent for
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
